Partner

Schiffbaustrasse 2, Postfach 1765
Zürich

8031

+41 58 552 03 20

Patent star 2024

Trade mark star 2024


Jurisdictions:

Switzerland

Practice areas:

IP transactions
Patent litigation
Trade mark litigation

Industry sectors:

Chemistry
Computer technology & services
Life sciences
Medical devices
Pharmaceutical


Simon Holzer is a member of MLL Legal's IP team, which is consistently ranked as one of the top Swiss IP teams by peers and clients, and heads the firm’s Patent and Life Sciences team. He has extensive experience in all areas of IP law, with a focus on patents, trademarks, geographical indications and unfair competition. Simon Holzer is also a trusted advisor in the field of pharmaceutical regulatory law.

Simon Holzer is an experienced IP litigator and has substantial experience in both advising and representing clients in complex national and inter-national disputes extending across a wide range of industries and technologies, including pharmaceuticals, medical devices, telecommunications (including Standard-Essential Patents and FRAND issues), software, cosmetics and foodstuffs.

In 2010 the Swiss Parliament appointed Simon Holzer as an adjunct judge of the Swiss Federal Patent Court. This court has jurisdiction over patent disputes throughout Switzerland. Simon Holzer is praised by clients and peers as a “skilled and driven individual” and “a leader in the contentious sphere” who is “top-ranked by peers” within the “excellent” and “high-flying” IP team of Meyerlustenberger Lachenal. According to clients, Simon Holzer is particularly well versed in the areas of patents and pharma and clients highlight his “in-depth technical understanding”. Other sources describe Simon Holzer as a “key life sciences expert” and a “superstar in patent litigation” as well as a “pleasure to work with”.

 

Practice areas:

Designs

IP transactions

Patent litigation

Patent strategy & counseling

 

Industry sectors:

Biotechnology

Chemistry

Computer technology & services

Fashion & luxury goods

Healthcare

Life sciences

Medical devices

Pharmaceutical

 

 

Last updated 29th August 2019